Join this webinar to hear from Concarlo’s CEO and CSO Dr. Stacy Blain and COO LisaMarie Casey as they discuss the science behind a remarkable breakthrough in the treatment of metastatic cancers.
The Cancer Moonshot: A 5 Year Review
Watch our webinar to learn about the incredible progress that’s being made to achieve these goals and what is still on the horizon.
RESI Innovator’s Pitch Challenge Winner
Concarlo wins the Innovator’s Pitch Challenge at RESI Jan 2021!
Targeting p27Kip1 to Treat Drug-Resistance Cancer
Stacy Blain, PhD, Founder, CSO and CEO
2019 Social Enterprise Conference
Stacy Blain was a panelist at Columbia University’s Social Enterprise Conference.
WE NYC Women in Tech Conference
Stacy Blain was a panelist at WE NYC’s annual summit, Female Founders Disrupting HealthTech, at the New York Genome Center.
Click here to download Stacy’s article: Targeting p27 tyrosine phosphorylation as a modality to inhibit CDK4 and CDK2 and cause cell cycle arrest in breast cancer cells.